Documentation Centre

January 18, 2021
Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial. Eur Heart J. 2020;41:2952-2961.
Ridker PM, MacFadyen JG, Glynn RJ, Bradwin G, Hasan AA, Rifai N

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiovascular Disease, Inflammation, Lipids/Lipoproteins